POZEN Logo
Print Page   Close Window

Press Release

POZEN to Present at Upcoming Investor Conferences

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Aug. 27, 2003--POZEN Inc. (NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the company's chairman, president and chief executive officer, will be speaking to investors at three upcoming investor conferences:

Thomas Weisel Partners Healthcare Tailwinds Conference on Wednesday, September 3, at 3:50 p.m. Eastern Time.

NewsMakers in the Biotech Industry Conference on Thursday, September 4, at 9:00 a.m. Eastern Time.

Bear Stearns 16th Annual Healthcare Conference on Monday, September 8, at 2:30 p.m. Eastern Time.

Dr. Plachetka will provide an overview of POZEN's business. The presentations will be webcast live and archived on POZEN's home page at www.pozen.com.

POZEN is a pharmaceutical company developing therapeutic advancements in a cost effective manner. Product development efforts are focused on diseases with unmet medical needs where POZEN can improve efficacy, safety, and/or patient convenience. Since its inception, POZEN has developed the largest and most advanced product pipeline in the field of migraine. POZEN has development and commercial alliances with GlaxoSmithKline and Nycomed. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.

CONTACT:
POZEN Inc.
Matt Czajkowski
Chief Financial Officer
919-913-1030
or
Lisa Barthelemy
Director, Investor Relations
919-913-1044